Skip to main content
S&P 5007,585.73-0.45%DOW52,093.11-0.63%NASDAQ25,981.57-0.78%BTC$75,900.00-1.51%ETH$2,404.54-3.20%GOLD$4,387.30+1.26%OIL$103.71-2.00%
Smart Investors Daily
ME

NASDAQ · MEDS

TRxADE HEALTH, Inc.

Healthcare · Medical - Pharmaceuticals

$1.62

Up+$0.75 (+87.22%)

Updated Sep 16, 2026, 7:09 AM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
13.28M
P/E ratio
-6.94
Dividend yield
0.00%
52-week range
— – —
Volume
65.06M
Avg. volume
73.36K

Price performance

MEDS price history

1M range · 20 trading sessions · Daily adjusted prices

MEDS closed at $1.62 after 20 trading sessions, up 17.39% for the selected period.

Last close
$1.62
Period change
+17.39%
Period low
$0.85
Period high
$1.62
Daily close
View OHLC price history
MEDS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 15, 2026$0.8949$3.85$0.865$1.6265.06M
Sep 14, 2026$0.88$0.8998$0.86$0.865356.67K
Sep 11, 2026$0.9072$0.935$0.8614$0.900187.97K
Sep 10, 2026$0.8799$0.903$0.8501$0.89280K
Sep 9, 2026$0.871$0.95$0.851$0.851148.64K
Sep 8, 2026$0.9153$0.9188$0.8526$0.8711136.68K
Sep 4, 2026$0.975$1.04$0.915$0.916312.92K
Sep 3, 2026$1.02$1.0299$0.951$0.961152.11K
Sep 2, 2026$0.9696$1.05$0.9321$1.03128.72K
Sep 1, 2026$0.94$1.02$0.9202$0.99138.09K
Aug 31, 2026$0.878$1.05$0.8225$0.9637.83M
Aug 28, 2026$1.15$1.17$0.9602$0.9606129.57K
Aug 27, 2026$1.20$1.28$1.16$1.17284.36K
Aug 26, 2026$1.35$1.3678$1.26$1.3352.8M
Aug 25, 2026$1.32$1.36$1.30$1.3642.73K
Aug 24, 2026$1.38$1.39$1.30$1.3035.95K
Aug 21, 2026$1.4318$1.51$1.36$1.3769.61K
Aug 20, 2026$1.43$1.4538$1.31$1.45208.33K
Aug 19, 2026$1.39$1.5684$1.34$1.43410.62K
Aug 18, 2026$1.45$1.50$1.38$1.3864.29K

Latest MEDS news

The latest Smart Investors Daily articles mentioning MEDS.

Stock researchCompany · Overview

MEDS research

Overview

Company profile and research snapshot.

Company profile

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$6.89
Implied upside
—
Analysts
—
MEDS recent ratings
DateFirmRatingTarget
May 16, 2023EF HuttonBuy—
Mar 28, 2023Maxim GroupBuy—
Dec 9, 2021EF HuttonBuy—
Dec 3, 2020National SecuritiesBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 8, 2026

Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout

Leading Healthcare IT Company and Former NFL Players Will Work Together to Provide Rural Communities Access to Telehealth and Pharmacy-based Services Through Health Lives Here Mobile AppTAMPA, FL / ACCESS Newswire / September 8, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™,and

Yahoo · Aug 14, 2026

DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of August 7, 2026

TAMPA, FL / ACCESS Newswire / August 14, 2026 /DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ ...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By